| Ivermectin and COVID-19: keeping rigor in times of urgency C Chaccour, F Hammann, S Ramón-García, NR Rabinovich The American journal of tropical medicine and hygiene 102 (6), 1156, 2020 | 219 | 2020 |
| The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled
C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ... EClinicalMedicine 32, 100720, 2021 | 199 | 2021 |
| Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects PC Dolder, Y Schmid, AE Steuer, T Kraemer, KM Rentsch, F Hammann, ... Clinical pharmacokinetics 56, 1219-1230, 2017 | 123 | 2017 |
| Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety C Chaccour, F Hammann, NR Rabinovich Malaria Journal 16 (1), 1-16, 2017 | 106 | 2017 |
| Green tea extract enhances parieto-frontal connectivity during working memory processing A Schmidt, F Hammann, B Wölnerhanssen, AC Meyer-Gerspach, J Drewe, ... Psychopharmacology 231 (19), 3879-3888, 2014 | 94 | 2014 |
| Prediction of adverse drug reactions using decision tree modeling F Hammann, H Gutmann, N Vogt, C Helma, J Drewe Clinical Pharmacology & Therapeutics 88 (1), 52-59, 2010 | 91 | 2010 |
| Computational prediction of blood-brain barrier permeability using decision tree induction C Suenderhauf, F Hammann, J Huwyler Molecules 17 (9), 10429-10445, 2012 | 86 | 2012 |
| Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone O Kummer, F Hammann, C Moser, O Schaller, J Drewe, S Krähenbühl European journal of clinical pharmacology 67, 63-71, 2011 | 83 | 2011 |
| Classification of Cytochrome P450 Activities Using Machine Learning Methods F Hammann, H Gutmann, U Baumann, C Helma, J Drewe Molecular pharmaceutics 6 (6), 1920-1926, 2009 | 59 | 2009 |
| Neural effects of green tea extract on dorsolateral prefrontal cortex S Borgwardt, F Hammann, K Scheffler, M Kreuter, J Drewe, C Beglinger European journal of clinical nutrition 66 (11), 1187-1192, 2012 | 57 | 2012 |
| Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls H Gutmann, P Hruz, C Zimmermann, A Straumann, L Terracciano, ... Digestion 78 (2-3), 154-162, 1952 | 57 | 1952 |
| Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital V Schöning, E Liakoni, C Baumgartner, AK Exadaktylos, WE Hautz, ... Journal of translational medicine 19, 1-11, 2021 | 43 | 2021 |
| Screening for an ivermectin slow-release formulation suitable for malaria vector control C Chaccour, ÁI Barrio, AGG Royo, DM Urbistondo, H Slater, F Hammann, ... Malaria Journal 14 (1), 1-9, 2015 | 43 | 2015 |
| An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatographytandem mass spectrometry S Sturm, F Hammann, J Drewe, HH Maurer, A Scholer Journal of Chromatography B 878 (28), 2726-2732, 2010 | 42 | 2010 |
| Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects PC Dolder, P Strajhar, P Vizeli, F Hammann, A Odermatt, ME Liechti Frontiers in pharmacology 8, 617, 2017 | 41 | 2017 |
| Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan O Kummer, M Haschke, F Hammann, M Bodmer, S Bruderer, Y Regnault, ... European journal of pharmaceutical sciences 38 (4), 384-388, 2009 | 41 | 2009 |
| Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats C Chaccour, G Abizanda, Á Irigoyen-Barrio, A Casellas, A Aldaz, ... Scientific reports 10 (1), 1-11, 2020 | 36 | 2020 |
| Combinatorial QSAR modeling of human intestinal absorption C Suenderhauf, F Hammann, A Maunz, C Helma, J Huwyler Molecular pharmaceutics 8 (1), 213-224, 2011 | 34 | 2011 |
| Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers U Duthaler, C Suenderhauf, MO Karlsson, J Hussner, ... British journal of clinical pharmacology 85 (3), 626-633, 2019 | 33 | 2019 |
| Prediction of clinically relevant drug‐induced liver injury from structure using machine learning F Hammann, V Schöning, J Drewe Journal of Applied Toxicology 39 (3), 412-419, 2019 | 32 | 2019 |
Juergen DreweUniversity of Basel,Patvirtintas el. paštas unibas.ch
